TORONTO — NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the “Company”) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice filed by NeuPath of its intention to renew its normal course issuer bid (“NCIB”). Under the NCIB, the Company may, during the 12-month period commencing December 4, 2025 and ending December 3, […]